Summary of Product Characteristics
last updated on the eMC:
18/12/2009
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 18/12/2009 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 4.3 - Contraindications
-
Change to section 4.4 - Special warnings and precautions for Use
-
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
-
Change to section 4.8 - Undesirable Effects
-
Change to section 4.9 - Overdose
-
Change to section 5.1 - Pharmacodynamic Properties
-
Change to section 5.2 - Pharmacokinetic Properties
|
| Date of revision of text on the SPC: 14-Dec-2009 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Update to SmPC following renewal.
|
|
Updated on 04/09/2009 and displayed until 18/12/2009
|
Reasons for adding or updating:
|
-
Improved Electronic Presentation
|
| Date of revision of text on the SPC: 11-May-2009 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| None provided |
|
Updated on 10/04/2008 and displayed until 04/09/2009
|
Reasons for adding or updating:
|
|
|
|
